Genetic Variants of <i>CITED2</i> Gene Promoter in Human Atrial Septal Defects: Case-Control Study and Cellular Functional Verification

Atrial septal defect (ASD) is one of the most common forms of congenital heart disease (CHD). Genetic variants in the coding region of the CITED2 gene are known to be significantly correlated with CHD, but the role of variants in the promoter region of CITED2 is unknown. We investigated variants in...

Full description

Bibliographic Details
Main Authors: Zhuo Chen, Huan-Xin Chen, Hai-Tao Hou, Xiu-Yun Yin, Qin Yang, Jun Han, Guo-Wei He
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Journal of Cardiovascular Development and Disease
Subjects:
Online Access:https://www.mdpi.com/2308-3425/9/10/321
_version_ 1797440827972124672
author Zhuo Chen
Huan-Xin Chen
Hai-Tao Hou
Xiu-Yun Yin
Qin Yang
Jun Han
Guo-Wei He
author_facet Zhuo Chen
Huan-Xin Chen
Hai-Tao Hou
Xiu-Yun Yin
Qin Yang
Jun Han
Guo-Wei He
author_sort Zhuo Chen
collection DOAJ
description Atrial septal defect (ASD) is one of the most common forms of congenital heart disease (CHD). Genetic variants in the coding region of the CITED2 gene are known to be significantly correlated with CHD, but the role of variants in the promoter region of CITED2 is unknown. We investigated variants in the promoter of the CITED2 gene in 625 subjects (332 ASD and 293 healthy controls) through Sanger sequencing. Four variants in the CITED2 gene promoter were found only in eight ASD patients with zero occurrence in the control subjects (one case of g.4078A>C(rs1165649373), one case of g.4240C>A(rs1235857801), four cases of g.4935C>T(rs111470468), two cases of g.5027C>T(rs112831934)). Cellular functional analysis showed that these four variants significantly changed the transcriptional activity of the CITED2 gene promoter in HEK-293 and HL-1 cells. Electrophoretic mobility change assay results and JASPAR database analysis demonstrated that these variants created or destroyed a series of possible transcription factor binding sites, resulting in changes in the expression of CITED2 protein. We conclude that the variants of CITED2 promoter in ASD patients affect the transcriptional activity and are likely involved in the occurrence and development of ASD. These findings provide new perspectives on the pathogenesis and potential therapeutic insights of ASD.
first_indexed 2024-03-09T12:14:04Z
format Article
id doaj.art-9eced2596b514c448ad57659efb21786
institution Directory Open Access Journal
issn 2308-3425
language English
last_indexed 2024-03-09T12:14:04Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series Journal of Cardiovascular Development and Disease
spelling doaj.art-9eced2596b514c448ad57659efb217862023-11-30T22:48:44ZengMDPI AGJournal of Cardiovascular Development and Disease2308-34252022-09-0191032110.3390/jcdd9100321Genetic Variants of <i>CITED2</i> Gene Promoter in Human Atrial Septal Defects: Case-Control Study and Cellular Functional VerificationZhuo Chen0Huan-Xin Chen1Hai-Tao Hou2Xiu-Yun Yin3Qin Yang4Jun Han5Guo-Wei He6School of Pharmacy, Drug Research & Development Center, Wannan Medical College, Wuhu, Anhui 241002, China and The Institute of Cardiovascular Diseases, TEDA International Cardiovascular Hospital, Tianjin University & Chinese Academy of Medical Sciences, Tianjin 300457, ChinaThe Institute of Cardiovascular Diseases and Department Cardiovascular Surgery, TEDA International Cardiovascular Hospital, Tianjin University and Chinese Academy of Medical Sciences, Tianjin 300457, ChinaThe Institute of Cardiovascular Diseases and Department Cardiovascular Surgery, TEDA International Cardiovascular Hospital, Tianjin University and Chinese Academy of Medical Sciences, Tianjin 300457, ChinaSchool of Pharmacy, Drug Research & Development Center, Wannan Medical College, Wuhu, Anhui 241002, China and The Institute of Cardiovascular Diseases, TEDA International Cardiovascular Hospital, Tianjin University & Chinese Academy of Medical Sciences, Tianjin 300457, ChinaThe Institute of Cardiovascular Diseases and Department Cardiovascular Surgery, TEDA International Cardiovascular Hospital, Tianjin University and Chinese Academy of Medical Sciences, Tianjin 300457, ChinaSchool of Pharmacy, Drug Research & Development Center, Wannan Medical College, Wuhu, Anhui 241002, ChinaSchool of Pharmacy, Drug Research & Development Center, Wannan Medical College, Wuhu, Anhui 241002, China and The Institute of Cardiovascular Diseases, TEDA International Cardiovascular Hospital, Tianjin University & Chinese Academy of Medical Sciences, Tianjin 300457, ChinaAtrial septal defect (ASD) is one of the most common forms of congenital heart disease (CHD). Genetic variants in the coding region of the CITED2 gene are known to be significantly correlated with CHD, but the role of variants in the promoter region of CITED2 is unknown. We investigated variants in the promoter of the CITED2 gene in 625 subjects (332 ASD and 293 healthy controls) through Sanger sequencing. Four variants in the CITED2 gene promoter were found only in eight ASD patients with zero occurrence in the control subjects (one case of g.4078A>C(rs1165649373), one case of g.4240C>A(rs1235857801), four cases of g.4935C>T(rs111470468), two cases of g.5027C>T(rs112831934)). Cellular functional analysis showed that these four variants significantly changed the transcriptional activity of the CITED2 gene promoter in HEK-293 and HL-1 cells. Electrophoretic mobility change assay results and JASPAR database analysis demonstrated that these variants created or destroyed a series of possible transcription factor binding sites, resulting in changes in the expression of CITED2 protein. We conclude that the variants of CITED2 promoter in ASD patients affect the transcriptional activity and are likely involved in the occurrence and development of ASD. These findings provide new perspectives on the pathogenesis and potential therapeutic insights of ASD.https://www.mdpi.com/2308-3425/9/10/321atrial septal defectCITED2geneticcardiacheart
spellingShingle Zhuo Chen
Huan-Xin Chen
Hai-Tao Hou
Xiu-Yun Yin
Qin Yang
Jun Han
Guo-Wei He
Genetic Variants of <i>CITED2</i> Gene Promoter in Human Atrial Septal Defects: Case-Control Study and Cellular Functional Verification
Journal of Cardiovascular Development and Disease
atrial septal defect
CITED2
genetic
cardiac
heart
title Genetic Variants of <i>CITED2</i> Gene Promoter in Human Atrial Septal Defects: Case-Control Study and Cellular Functional Verification
title_full Genetic Variants of <i>CITED2</i> Gene Promoter in Human Atrial Septal Defects: Case-Control Study and Cellular Functional Verification
title_fullStr Genetic Variants of <i>CITED2</i> Gene Promoter in Human Atrial Septal Defects: Case-Control Study and Cellular Functional Verification
title_full_unstemmed Genetic Variants of <i>CITED2</i> Gene Promoter in Human Atrial Septal Defects: Case-Control Study and Cellular Functional Verification
title_short Genetic Variants of <i>CITED2</i> Gene Promoter in Human Atrial Septal Defects: Case-Control Study and Cellular Functional Verification
title_sort genetic variants of i cited2 i gene promoter in human atrial septal defects case control study and cellular functional verification
topic atrial septal defect
CITED2
genetic
cardiac
heart
url https://www.mdpi.com/2308-3425/9/10/321
work_keys_str_mv AT zhuochen geneticvariantsoficited2igenepromoterinhumanatrialseptaldefectscasecontrolstudyandcellularfunctionalverification
AT huanxinchen geneticvariantsoficited2igenepromoterinhumanatrialseptaldefectscasecontrolstudyandcellularfunctionalverification
AT haitaohou geneticvariantsoficited2igenepromoterinhumanatrialseptaldefectscasecontrolstudyandcellularfunctionalverification
AT xiuyunyin geneticvariantsoficited2igenepromoterinhumanatrialseptaldefectscasecontrolstudyandcellularfunctionalverification
AT qinyang geneticvariantsoficited2igenepromoterinhumanatrialseptaldefectscasecontrolstudyandcellularfunctionalverification
AT junhan geneticvariantsoficited2igenepromoterinhumanatrialseptaldefectscasecontrolstudyandcellularfunctionalverification
AT guoweihe geneticvariantsoficited2igenepromoterinhumanatrialseptaldefectscasecontrolstudyandcellularfunctionalverification